Alizyme Phase Ia data

Alizyme (LSE:AZM) said that in a placebo-controlled single-dose Phase Ia trial in 32 healthy volunteers, all four doses of ATL-962, a lipase inhibitor that prevents dietary lipid digestion, were well ...